Abstract:Corticosteroid actions in the brain are exerted via the mineralocorticoid receptor (MR) and glucocorticoid receptor (GR). These receptors share several structural and functional similarities but their activation in the brain triggers distinct biological actions, for instance on neuronal survival or the regulation of the hypothalamo-pituitary-adrenal axis. Like other hormone-activated receptors, the transcriptional properties of the MR and GR depend on their ability to recruit a variety of co-regulators, which modulate their activity on target promoters, in a specific manner. The N-terminal regions of the MR and GR share the smallest degree of sequence conservation, whereas they display opposite effects on the transactivation properties of these receptors; thus, they may provide surfaces suitable for receptorspecific interactions with co-regulatory proteins. Here, we employed a yeast two-hybrid system to identify molecules interacting with the N-terminal part of the MR (amino acids 170-433). This approach resulted in the isolation of representative cDNAs from all members of the protein inhibitor of activated STAT (PIAS) family of proteins as potential MR-interacting partners. In neural cells, PIAS3 exhibited a strong and specific interaction with MR, but not GR, as indicated by mammalian two-hybrid assays and co-immunoprecipitation experiments in vivo. The interaction with MR was enhanced in the presence of aldosterone, an MR agonist, and was found to occur through a conserved, serine- and acidic amino acid residue-rich domain of PIAS3. To compare the modulatory properties of PIAS proteins on MR and GR transcriptional activity in a neural environment, MMTV reporter gene assays were performed in the human neuroblastoma cell line SK-N-MC. This analysis revealed that PIAS3 can inhibit MR, but not GR, transactivation in response to their corresponding ligands. Further, it showed that PIAS1 and PIASxbeta, but not PIASy, could also inhibit MR-mediated transcription despite the lack of detected physical interaction with MR. Interestingly, PIASxbeta and PIASy dose-dependently co-activated GR, whereas PIAS1 impaired GR-induced transcription. Taken together the results reveal differential modulatory roles of the PIAS proteins on the transcriptional properties of MR and GR, thus providing new insights into the bifurcating actions of these two receptors in neural cells where they are frequently co-localized.

PIAS3 Induction of PRB Sumoylation Represses PRB Transactivation by Destabilizing Its Retention in the Nucleus

PAQR3 Modulates H3K4 Trimethylation by Spatial Modulation of the Regulatory Subunits of COMPASS-like Complexes in Mammalian Cells.

PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1

The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.

[SUMO-2/3 Can Covalently Bind to Progesterone Receptor B to Regulate Its Transcriptional Activity].

The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells

SUMO3 Modification by PIAS1 Modulates Androgen Receptor Cellular Distribution and Stability

Integrity of the LXXLL Motif in Stat6 is Required for the Inhibition of Breast Cancer Cell Growth and Enhancement of Differentiation in the Context of Progesterone

Expression of PIAS3 an Inhibitor of Activated STAT3 Protein in Human Prostate Cancer

SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin

TRPS1 Regulates the Opposite Effect of Progesterone Via RANKL in Endometrial Carcinoma and Breast Carcinoma

A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors

Protein Inhibitors of Activated STAT (Pias1 and Piasy) Differentially Regulate Pituitary Homeobox 2 (PITX2) Transcriptional Activity*

Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation

CUE Domain Containing 2 Regulates Degradation of Progesterone Receptor by Ubiquitin–proteasome

Structural proteomics defines a sequential priming mechanism for the progesterone receptor

Blockage of Progesterone Receptor Effectively Protects Pancreatic Islet Beta Cell Viability.

Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation <i>via</i> direct binding of histones H3 and H2A.Z

5′-Amp-activated Protein Kinase (AMPK) Regulates Progesterone Receptor Transcriptional Activity in Breast Cancer Cells

Regulation of the SUMO Pathway Sensitizes Differentiating Human Endometrial Stromal Cells to Progesterone

P38 alpha MAPK is a gatekeeper of uterine progesterone responsiveness at peri-implantation via Ube3c-mediated PGR degradation